Inflammatory passage of plasma macromolecules into airway wall and lumen.
about
The role of platelet activating factor in allergic respiratory diseaseAirway vasculature after mycoplasma infection: chronic leakiness and selective hypersensitivity to substance P.Pharmacologic control of plasma exudation into tracheobronchial airways.Effects of topical capsaicin in seasonal allergic rhinitis.In vivo paradigms of diseased airway mucosa: selected aspects of innate immunity and eosinophils.Positive interaction of the beta2-agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea-pigs.Physiologic control. Anatomy and physiology of the airway circulation.Effects of inhaled histamine, methacholine and capsaicin on sputum levels of alpha 2-macroglobulinQuantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykininBradykinin-induced airflow obstruction and airway plasma exudation: effects of drugs that inhibit acetylcholine, thromboxane A2 or leukotrienesKinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivoInhaled drugs and the lung.Plasma exudation as a first line respiratory mucosal defence.The 'nasal pool' device applies controlled concentrations of solutes on human nasal airway mucosa and samples its surface exudations/secretions.Plasma exudation and solute absorption across the airway mucosa.Clearance of 99mTc DTPA from guinea pig nasal, tracheobronchial, and bronchoalveolar airways.Absorption of 51Cr EDTA across the human nasal airway barriers in the presence of topical histamine.Effects of histamine, ethanol, and a detergent on exudation and absorption across guinea pig airway mucosa in vivo.Effects of nicotine on the human nasal mucosa.Microvascular exudative hyperresponsiveness in human coronavirus-induced common cold.Effects of topical budesonide on epithelial restitution in vivo in guinea pig tracheaAnti-inflammatory effects of theophylline and selective phosphodiesterase inhibitors.Epithelium, microcirculation, and eosinophils--new aspects of the allergic airway in vivo.The use of the nose to study the inflammatory response of the respiratory tract.Formoterol and salbutamol inhibit bradykinin- and histamine-induced airway microvascular leakage in guinea-pig.On the use of absorbing discs to sample mucosal surface liquids.Long duration and high potency of antiexudative effects of formoterol in guinea-pig tracheobronchial airways.Day-night differences in mucosal plasma proteins in common cold.Increased sensitivity to toluene diisocyanate (TDI) in airways previously exposed to low doses of TDI.Epithelial pathways for luminal entry of bulk plasma.Allergen-induced biphasic plasma exudation responses in guinea pig large airways.Topical nitroprusside may reduce histamine-induced plasma exudation in human nasal airways.Allergen challenge-induced extravasation of plasma in mouse airways.Prolonged airway activity and improved selectivity of budesonide possibly due to esterification.Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage.Allergen, bradykinin, and capsaicin increase outward but not inward macromolecular permeability of guinea-pig tracheobronchial mucosa.125I-albumin may not be used as a tracer of absorption across the human nasal airway barriers.Mucosal Exudation of Fibrinogen in Coronavirus-induced Common Colds
P2860
Q28768533-3D9E1F46-A5B4-4377-B8ED-A843BEF17D12Q31834119-9E8F82D8-980F-4DA3-BF02-CE63951ACACFQ33386401-03FC0B38-B7B2-4C03-92EC-0FEB74B3B17BQ33604763-D17EF2EF-200C-4690-8A3B-D2D96A5D5DA1Q33775596-B7D6401F-700B-45C0-923A-D4FE1B481EDBQ35048615-E5E66C89-7DEA-4746-92AC-1C3585DBD655Q35534427-09D32DDB-0D1A-49F0-A6FC-6CA5FEF6FEAFQ35563241-0B7B4F11-ADD9-4E8B-8F93-5B5A20F7000EQ35871902-C15764CF-1E66-48C1-99D9-DF50081FF8DAQ36330183-85903B0F-9AD3-4BEA-B6A5-1A117651E7DDQ36380566-F7644229-F258-482B-BE4E-1EE82182FAD4Q37220873-9F75F7B3-AB2A-4807-84DA-A491D16F5134Q37706514-719D16D5-D84E-49AF-B71E-290C46D255D6Q40762344-3952DDDB-E97B-48EF-97C4-8A729D44AA4BQ40921215-A603D65D-C860-4747-BC69-E0B4116DA484Q41140346-0118FEB2-F152-4DA4-AE07-98586D43FC8AQ41143666-9C4E6651-46F0-4672-85F3-A33AA988DD0BQ41143899-A243B9DB-D63C-41F7-BF3A-AF61FDA7767EQ41150954-A76EA090-98BD-4361-9974-CA8FC04CEB70Q41226414-052433A8-0EFE-4508-9A75-92D75A50827CQ41229440-FCCADD95-12BD-48AD-A0EB-C0FD72CF46C8Q41267865-4DD6C45A-8278-4865-989D-4A294A1D289FQ41462058-226EB796-EEDA-40C9-8AD3-FCAA61C984D0Q41827995-1949BDA8-BD61-4FEC-B95B-F675A56161A9Q41892638-9CB1BFE9-219E-4504-8EBA-F7A68E50BC50Q44689970-A3818FFD-C6DF-4726-98C7-C666B52F54B8Q45028401-FD327AAC-C123-4DCC-B724-EAE2248F07BBQ45205732-F4905D4F-7EA5-41D8-B998-5C378C1ECD46Q46410431-79844677-0C40-4009-9C4C-B6D209AF8A7CQ46444576-0D957B43-F95F-4079-848D-21C614648006Q46481407-6C2C75E3-4AFF-4DBC-ABBD-696CB4D94934Q46855129-0F0F26D5-6DC6-4ACD-ADCD-064B11E5E3B0Q50522469-3C46CB7E-639B-45B8-B75B-CAF42E255FBFQ50758361-956CD4F7-26E0-4DB7-9815-A283EF1BF314Q50803254-4BC5525F-F563-42B2-B1BE-B402CD6D7758Q53862128-F79F5DF5-6FF5-410D-BE02-B76CAB7167F0Q54287774-2F6023F9-9988-4ED9-95AA-E1D5D2BAB86FQ58251366-256E9BEA-7446-47B5-B60D-27A321400FCC
P2860
Inflammatory passage of plasma macromolecules into airway wall and lumen.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Inflammatory passage of plasma macromolecules into airway wall and lumen.
@en
type
label
Inflammatory passage of plasma macromolecules into airway wall and lumen.
@en
prefLabel
Inflammatory passage of plasma macromolecules into airway wall and lumen.
@en
P1476
Inflammatory passage of plasma macromolecules into airway wall and lumen.
@en
P2093
Erjefält I
Persson CG
P304
P356
10.1016/0952-0600(89)90030-6
P577
1989-01-01T00:00:00Z